• 1
    Reginster JY. The prevalence and burden of arthritis. Rheumatology (Oxford) 2005; 41 Suppl: 36.
  • 2
    Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty: a qualitative and systematic review of the literature. J Bone Joint Surg Am 2004; 86: 96374.
  • 3
    Ahmad MA, Xypnitos FN, Giannoudis PV. Measuring hip outcomes: common scales and checklists. Injury 2011; 42: 25964.
  • 4
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 183340.
  • 5
    Crowninshield RD, Rosenberg AG, Spore SM. Changing demographics of patients with total joint replacement. Clin Orthop Relat Res 2006; 443: 26672.
  • 6
    Mahomed NN, Liang MH, Cook EF, Daltroy LH, Fortin PR, Fossel AH, et al. The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. J Rheumatol 2002; 29: 12739.
  • 7
    Naal FD, Impellizzeri FM. How active are patients undergoing total joint arthroplasty: a systematic review. Clin Orthop Relat Res 2010; 468: 1891904.
  • 8
    Martin RL, Kelly BT, Philippon MJ. Evidence of validity for the Hip Outcome Score. Arthroscopy 2006; 22: 130411.
  • 9
    Martin RL, Philippon MJ. Evidence of validity for the Hip Outcome Score in hip arthroscopy. Arthroscopy 2007; 23: 8226.
  • 10
    Martin RL, Philippon MJ. Evidence of reliability and responsiveness for the Hip Outcome Score. Arthroscopy 2008; 24: 67682.
  • 11
    Naal FD, Impellizzeri FM, Miozzari HH, Mannion AF, Leunig M. The German Hip Outcome Score: validation in patients undergoing surgical treatment for femoroacetabular impingement. Arthroscopy 2011; 27: 33945.
  • 12
    Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 3442.
  • 13
    Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med 1998; 17: 10110.
  • 14
    Cohen J. Statistical power analysis for the behavioral sciences. Mahwah (NJ): Lawrence Erlbaum; 1988.
  • 15
    Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 1995.
  • 16
    Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model 1999; 6: 155.
  • 17
    Steiger JH. Understanding the limitations of global fit assessment in structural equation modeling. Pers Indiv Differ 2000; 42: 8938.
  • 18
    Mannion AF, Junge A, Fairbank JC, Dvorak J, Grob D. Development of a German version of the Oswestry Disability Index. Part 1: cross-cultural adaptation, reliability, and validity. Eur Spine J 2006; 15: 5565.
  • 19
    Stratford PW, Spadoni G, Kennedy D, Westaway MD, Alcock GK. Seven points to consider when investigating a measure's ability to detect change. Physiother Can 2002; 54: 1624.
  • 20
    Naal FD, Sieverding M, Impellizzeri FM, von Knoch F, Mannion AF, Leunig M. Reliability and validity of the cross-culturally adapted German Oxford Hip Score. Clin Orthop Relat Res 2009; 467: 9527.